These stable isoforms, namely PD-L1v229 and PD-L1v242 (Figure 4), were shown to act as decoys and bind to PD-L1 blockade in vitro as a result promoting the PD-L1 and PD-1 interaction, which further suppressed the anti-tumor immunity (Table 1). Here, CD274 is linked to neoplasm.